日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.

重组VSV-HIV初免、DNA加强疫苗候选物对SHIV感染恒河猴免疫原性和病毒血症的影响

Berger Alice, Pedersen Jannie, Kowatsch Monika M, Scholte Florine, Lafrance Marc-Alexandre, Azizi Hiva, Li Yue, Gomez Alejandro, Wade Matthew, Fausther-Bovendo Hugues, de La Vega Marc-Antoine, Jelinski Joseph, Babuadze George, Nepveu-Traversy Marie-Edith, Lamarre Claude, Racine Trina, Kang Chil-Yong, Gaillet Bruno, Garnier Alain, Gilbert Rénald, Kamen Amine, Yao Xiao-Jian, Fowke Keith R, Arts Eric, Kobinger Gary

The First Assessments of Pediatric HBV Immunization Coverage in Mauritania and Persistence of Antibody Titers Post Infant Immunizations

毛里塔尼亚儿童乙肝疫苗接种覆盖率的首次评估及婴儿接种疫苗后抗体滴度的持久性

El Hachimi, Hala; El Alem, Mohamed Mahmoud Mohamed; Haimoudane, Esma; Yebouk, Cheikh; Pedersen, Jannie; Fall-Malick, F-Zahra; Khiddi, Fatimetou; Abdawe, Mohamed; Sadegh, Sidi Ahmed; Fausther-Bovendo, Hugues; Mohamed Abdellahi, Mohamed Vall

Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV

源自已批准的埃博拉疫苗rVSV-ZEBOV的HIV-1疫苗的最佳表达、功能和免疫原性

Azizi, Hiva; Knapp, Jason P; Li, Yue; Berger, Alice; Lafrance, Marc-Alexandre; Pedersen, Jannie; de la Vega, Marc-Antoine; Racine, Trina; Kang, Chil-Yong; Mann, Jamie F S; Dikeakos, Jimmy D; Kobinger, Gary; Arts, Eric J

Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters

两种DNA疫苗可保护叙利亚仓鼠免受SARS-CoV-2引起的严重疾病和病理影响

Babuadze, George Giorgi; Fausther-Bovendo, Hugues; deLaVega, Marc-Antoine; Lillie, Brandon; Naghibosadat, Maedeh; Shahhosseini, Nariman; Joyce, Michael A; Saffran, Holly A; Lorne Tyrrell, D; Falzarano, Darryl; Senthilkumaran, Chandrika; Christie-Holmes, Natasha; Ahn, Steven; Gray-Owen, Scott D; Banerjee, Arinjay; Mubareka, Samira; Mossman, Karen; Dupont, Chanel; Pedersen, Jannie; Lafrance, Mark-Alexandre; Kobinger, Gary P; Kozak, Robert

Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic

中非和西非人群中针对SARS-CoV-2 N蛋白的交叉反应性免疫先于COVID-19大流行出现。

Pedersen, Jannie; Koumakpayi, Ismaël Hervé; Babuadze, Giorgi; Baz, Mariana; Ndiaye, Oumar; Faye, Oumar; Diagne, Cheikh Tidiane; Dia, Ndongo; Naghibosadat, Maedeh; McGeer, Allison; Muberaka, Samira; Moukandja, Irène P; Ndidi, Stella; Tauil, Carlos B; Lekana-Douki, Jean-Bernard; Loucoubar, Cheikh; Faye, Ousmane; Sall, Amadou; Magalhães, Kelly G; Weis, Nina; Kozak, Robert; Kobinger, Gary P; Fausther-Bovendo, Hugues

Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?

冠状病毒感染疫苗候选药物。新冠肺炎疫苗研发进展如何?

Al-Kassmy, Jawad; Pedersen, Jannie; Kobinger, Gary

Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a

针对HCV基因型1a、1b、2a、2b、2c和3a的临床相关人源单克隆抗体的中和广度和协同作用

Carlsen, Thomas H R; Pedersen, Jannie; Prentoe, Jannick C; Giang, Erick; Keck, Zhen-Yong; Mikkelsen, Lotte S; Law, Mansun; Foung, Steven K H; Bukh, Jens

Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies

重组人单克隆抗体可以克服丙型肝炎病毒的中和耐药性。

Pedersen, Jannie; Carlsen, Thomas H R; Prentoe, Jannick; Ramirez, Santseharay; Jensen, Tanja B; Forns, Xavier; Alter, Harvey; Foung, Steven K H; Law, Mansun; Gottwein, Judith; Weis, Nina; Bukh, Jens